117 related articles for article (PubMed ID: 14970265)
21. Differentiation therapy of acute promyelocytic leukemia: clinical and molecular features.
Miller WH
Cancer Invest; 1996; 14(2):142-50. PubMed ID: 8597899
[No Abstract] [Full Text] [Related]
22. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts.
Testa U; Grignani F; Samoggia P; Zanetti C; Riccioni R; Lo Coco F; Diverio D; Felli N; Passerini CG; Grell M; Pelicci PG; Peschle C
J Clin Invest; 1998 May; 101(10):2278-89. PubMed ID: 9593784
[TBL] [Abstract][Full Text] [Related]
23. A PMLRARalpha transgene initiates murine acute promyelocytic leukemia.
Brown D; Kogan S; Lagasse E; Weissman I; Alcalay M; Pelicci PG; Atwater S; Bishop JM
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2551-6. PubMed ID: 9122233
[TBL] [Abstract][Full Text] [Related]
24. The promyelocytic leukemia protein stimulates SUMO conjugation in yeast.
Quimby BB; Yong-Gonzalez V; Anan T; Strunnikov AV; Dasso M
Oncogene; 2006 May; 25(21):2999-3005. PubMed ID: 16501610
[TBL] [Abstract][Full Text] [Related]
25. Molecular pathology of acute promyelocytic leukemia.
Chang KS
Hematol Pathol; 1993; 7(4):209-23. PubMed ID: 8113150
[No Abstract] [Full Text] [Related]
26. APL, a model disease for cancer therapies?
de Thé H; Chelbi-Alix MK
Oncogene; 2001 Oct; 20(49):7136-9. PubMed ID: 11704841
[No Abstract] [Full Text] [Related]
27. Retinoid receptors in development and disease.
Schulman IG; Evans RM
Leukemia; 1997 Apr; 11 Suppl 3():376-7. PubMed ID: 9209395
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous detection of type A and type B PML/retinoic acid receptor alpha fusion transcripts in acute promyelocytic leukemia.
Kohli V; Koller CA
Blood; 1995 Feb; 85(3):854-5. PubMed ID: 7833490
[No Abstract] [Full Text] [Related]
29. On the differentiative mode of action of All-trans retinoic acid in acute promyelocytic leukemia.
Lo Coco F; Diverio D; Avvisati G; Mandelli F; Biondi A; Pelicci PG
Blood; 1995 Oct; 86(8):3264-5. PubMed ID: 7579425
[No Abstract] [Full Text] [Related]
30. Clastosome: a subtype of nuclear body enriched in 19S and 20S proteasomes, ubiquitin, and protein substrates of proteasome.
Lafarga M; Berciano MT; Pena E; Mayo I; Castaño JG; Bohmann D; Rodrigues JP; Tavanez JP; Carmo-Fonseca M
Mol Biol Cell; 2002 Aug; 13(8):2771-82. PubMed ID: 12181345
[TBL] [Abstract][Full Text] [Related]
31. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins.
Zhong S; Delva L; Rachez C; Cenciarelli C; Gandini D; Zhang H; Kalantry S; Freedman LP; Pandolfi PP
Nat Genet; 1999 Nov; 23(3):287-95. PubMed ID: 10610177
[TBL] [Abstract][Full Text] [Related]
32. Retinoid signaling is attenuated by proteasome-mediated degradation of retinoid receptors in human keratinocyte HaCaT cells.
Boudjelal M; Voorhees JJ; Fisher GJ
Exp Cell Res; 2002 Mar; 274(1):130-7. PubMed ID: 11855864
[TBL] [Abstract][Full Text] [Related]
33. [Role of retinoic acid in the treatment of acute promyelocytic leukemia].
Gutiérrez de Guzmán J; Kantarjian H
Sangre (Barc); 1993 Oct; 38(5):375-8. PubMed ID: 8140499
[No Abstract] [Full Text] [Related]
34. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
Grignani F; De Matteis S; Nervi C; Tomassoni L; Gelmetti V; Cioce M; Fanelli M; Ruthardt M; Ferrara FF; Zamir I; Seiser C; Grignani F; Lazar MA; Minucci S; Pelicci PG
Nature; 1998 Feb; 391(6669):815-8. PubMed ID: 9486655
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.
Mologni L; Marchesi E; Nielsen PE; Gambacorti-Passerini C
Cancer Res; 2001 Jul; 61(14):5468-73. PubMed ID: 11454693
[TBL] [Abstract][Full Text] [Related]
36. Interferon gamma regulates accumulation of the proteasome activator PA28 and immunoproteasomes at nuclear PML bodies.
Fabunmi RP; Wigley WC; Thomas PJ; DeMartino GN
J Cell Sci; 2001 Jan; 114(Pt 1):29-36. PubMed ID: 11112687
[TBL] [Abstract][Full Text] [Related]
37. Proteins associated with the promyelocytic leukemia gene product (PML)-containing nuclear body move to the nucleolus upon inhibition of proteasome-dependent protein degradation.
Mattsson K; Pokrovskaja K; Kiss C; Klein G; Szekely L
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1012-7. PubMed ID: 11158586
[TBL] [Abstract][Full Text] [Related]
38. Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor gamma and retinoid X receptor alpha in human keratinocytes.
Boudjelal M; Wang Z; Voorhees JJ; Fisher GJ
Cancer Res; 2000 Apr; 60(8):2247-52. PubMed ID: 10786691
[TBL] [Abstract][Full Text] [Related]
39. Marked for death.
Petrie K; Zelent A
Nat Cell Biol; 2008 May; 10(5):507-9. PubMed ID: 18454129
[No Abstract] [Full Text] [Related]
40. Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells.
Weis K; Rambaud S; Lavau C; Jansen J; Carvalho T; Carmo-Fonseca M; Lamond A; Dejean A
Cell; 1994 Jan; 76(2):345-56. PubMed ID: 8293468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
